$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

DNAJB1 negatively regulates MIG6 to promote epidermal growth factor receptor signaling 원문보기

Biochimica et biophysica acta, Molecular cell research, v.1853 no.10 pt.A, 2015년, pp.2722 - 2730  

Park, S.Y. ,  Choi, H.K. ,  Seo, J.S. ,  Yoo, J.Y. ,  Jeong, J.W. ,  Choi, Y. ,  Choi, K.C. ,  Yoon, H.G.

Abstract AI-Helper 아이콘AI-Helper

Mitogen-inducible gene 6 (MIG6) is a tumor suppressor implicated in the development of human cancers; however, the regulatory mechanisms of MIG6 remain unknown. Here, using a yeast two-hybrid screen, we identified DnaJ homolog subfamily B member I (DNAJB1) as a novel MIG6-interacting protein. We fou...

주제어

참고문헌 (44)

  1. Biol. Chem. Hackel 382 1649 2001 10.1515/BC.2001.200 Mig-6 is a negative regulator of the epidermal growth factor receptor signal 

  2. Hepatology Reschke 51 1383 2010 10.1002/hep.23428 Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma 

  3. Oncogene Anastasi 24 4540 2005 10.1038/sj.onc.1208658 Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin 

  4. J. Clin. Endocrinol. Metab. Lin 96 E554 2011 10.1210/jc.2010-1800 Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer 

  5. EMBO Rep. Ballaro 6 755 2005 10.1038/sj.embor.7400458 Targeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a waved-like phenotype 

  6. Nat. Med. Ferby 12 568 2006 10.1038/nm1401 Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation 

  7. Cancer Res. Kim 73 5090 2013 10.1158/0008-5472.CAN-13-0241 Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer 

  8. Proc. Natl. Acad. Sci. U. S. A. Jeong 106 8677 2009 10.1073/pnas.0903632106 Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease 

  9. Cancer Res. Kim 74 7371 2014 10.1158/0008-5472.CAN-14-0794 Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation 

  10. Cell Cycle Zhang 6 507 2007 10.4161/cc.6.5.3928 Mig-6, signal transduction, stress response and cancer 

  11. Am. J. Physiol. Lung Cell. Mol. Physiol. Ma 289 L468 2005 10.1152/ajplung.00109.2005 Bioinformatic identification of novel early stress response genes in rodent models of lung injury 

  12. J. Biol. Chem. Makkinje 275 17838 2000 10.1074/jbc.M909735199 Gene 33/Mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK. A potential marker transcript for chronic pathologic conditions, such as diabetic nephropathy. Possible role in the response to persistent stress 

  13. Mol. Cell. Biol. Xu 26 5043 2006 10.1128/MCB.02387-05 Gene 33/RALT is induced by hypoxia in cardiomyocytes, where it promotes cell death by suppressing phosphatidylinositol 3-kinase and extracellular signal-regulated kinase survival signaling 

  14. Proc. Natl. Acad. Sci. U. S. A. Zhang 102 11740 2005 10.1073/pnas.0505171102 Targeted disruption of Mig-6 in the mouse genome leads to early onset degenerative joint disease 

  15. Nat. Rev. Mol. Cell Biol. Saibil 14 630 2013 10.1038/nrm3658 Chaperone machines for protein folding, unfolding and disaggregation 

  16. Genes Dev. Gottesman 11 815 1997 10.1101/gad.11.7.815 Protein quality control: triage by chaperones and proteases 

  17. Nature Hartl 381 571 1996 10.1038/381571a0 Molecular chaperones in cellular protein folding 

  18. Science Bohen 268 1303 1995 10.1126/science.7761850 Hold 'em and fold 'em: chaperones and signal transduction 

  19. Clin. Exp. Metastasis Mitra 26 559 2009 10.1007/s10585-009-9255-x Multi-faceted role of HSP40 in cancer 

  20. Int. J. Biochem. Cell Biol. Kostenko 47 29 2014 10.1016/j.biocel.2013.11.004 Phosphorylation of heat shock protein 40 

  21. EMBO J. King 20 6297 2001 10.1093/emboj/20.22.6297 Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53 

  22. Cell Death Differ. Gotoh 8 357 2001 10.1038/sj.cdd.4400829 hsp70-DnaJ chaperone pairs prevent nitric oxide-mediated apoptosis in RAW 264.7 macrophages 

  23. Cell Death Differ. Gotoh 11 390 2004 10.1038/sj.cdd.4401369 hsp70-DnaJ chaperone pair prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of Bax to mitochondria 

  24. Cancer Lett. Cui 357 307 2015 10.1016/j.canlet.2014.11.041 DNAJB1 destabilizes PDCD5 to suppress p53-mediated apoptosis 

  25. Oncogene Fiorini 21 6530 2002 10.1038/sj.onc.1205823 Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control 

  26. Biochim. Biophys. Acta Pickart 1695 55 2004 10.1016/j.bbamcr.2004.09.019 Ubiquitin: structures, functions, mechanisms 

  27. FEBS Lett. Ramadan 585 2868 2011 10.1016/j.febslet.2011.04.046 Degradation-linked ubiquitin signal and proteasome are integral components of DNA double strand break repair: new perspectives for anti-cancer therapy 

  28. Nat. Immunol. Ahmed 12 1176 2011 10.1038/ni.2157 The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation 

  29. Nat. Rev. Cancer Hynes 5 341 2005 10.1038/nrc1609 ERBB receptors and cancer: the complexity of targeted inhibitors 

  30. BMC Syst. Biol. Naruo 5 29 2011 10.1186/1752-0509-5-29 Epidermal growth factor receptor mutation in combination with expression of MIG6 alters gefitinib sensitivity 

  31. Ann. N. Y. Acad. Sci. Morano 1113 1 2007 10.1196/annals.1391.018 New tricks for an old dog: the evolving world of Hsp70 

  32. Cancer Res. Schmitt 66 4191 2006 10.1158/0008-5472.CAN-05-3778 Heat shock protein 70 neutralization exerts potent antitumor effects in animal models of colon cancer and melanoma 

  33. Curr. Opin. Pharmacol. Taldone 8 370 2008 10.1016/j.coph.2008.06.015 Targeting Hsp90: small-molecule inhibitors and their clinical development 

  34. Biochem. Soc. Trans. Chapple 32 640 2004 10.1042/BST0320640 Neuronal DnaJ proteins HSJ1a and HSJ1b: a role in linking the Hsp70 chaperone machine to the ubiquitin-proteasome system? 

  35. Nat. Cell Biol. Fang 16 1227 2014 10.1038/ncb3054 Rsp5/Nedd4 is the main ubiquitin ligase that targets cytosolic misfolded proteins following heat stress 

  36. Mol. Cell. Biol. Lee 16 4773 1996 10.1128/MCB.16.9.4773 Involvement of the molecular chaperone Ydj1 in the ubiquitin-dependent degradation of short-lived and abnormal proteins in Saccharomyces cerevisiae 

  37. Oncogene Kim 29 3770 2010 10.1038/onc.2010.126 The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression 

  38. Oncol. Rep. Li 31 1707 2014 10.3892/or.2014.3050 Low expression of Mig-6 is associated with poor survival outcome in NSCLC and inhibits cell apoptosis via ERK-mediated upregulation of Bcl-2 

  39. J. Cell Biol. Frosi 189 557 2010 10.1083/jcb.201002032 A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation 

  40. J. Cell Sci. Walsh 126 4339 2013 10.1242/jcs.123208 Regulation of EGFR trafficking and cell signaling by Sprouty2 and MIG6 in lung cancer cells 

  41. Nat. Rev. Cancer Herbst 4 956 2004 10.1038/nrc1506 Gefitinib-a novel targeted approach to treating cancer 

  42. PLoS Med. Pao 2 e73 2005 10.1371/journal.pmed.0020073 Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain 

  43. Nat. Rev. Clin. Oncol. Wheeler 7 493 2010 10.1038/nrclinonc.2010.97 Understanding resistance to EGFR inhibitors-impact on future treatment strategies 

  44. Int. J. Clin. Exp. Pathol. Li 7 7304 2014 Mig-6 overcomes gefitinib resistance by inhibiting EGFR/ERK pathway in non-small cell lung cancer cell lines 

LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로